Compare XGN & MNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | XGN | MNY |
|---|---|---|
| Founded | 2002 | 2014 |
| Country | United States | Singapore |
| Employees | N/A | 240 |
| Industry | Medical Specialities | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 110.7M | 41.9M |
| IPO Year | 2014 | N/A |
| Metric | XGN | MNY |
|---|---|---|
| Price | $4.80 | $1.05 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 1 |
| Target Price | ★ $8.86 | $4.00 |
| AVG Volume (30 Days) | ★ 225.0K | 32.2K |
| Earning Date | 05-11-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $8.12 | N/A |
| Revenue Next Year | $13.00 | $19.58 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.59 | $0.78 |
| 52 Week High | $12.23 | $2.40 |
| Indicator | XGN | MNY |
|---|---|---|
| Relative Strength Index (RSI) | 60.81 | 43.12 |
| Support Level | $4.08 | $0.78 |
| Resistance Level | $5.55 | $1.03 |
| Average True Range (ATR) | 0.32 | 0.07 |
| MACD | 0.06 | 0.02 |
| Stochastic Oscillator | 95.74 | 30.86 |
Exagen Inc is a medical technology company focused on the design, development and commercialization of diagnostic testing products under its AVISE brand. These products are used for the differential diagnosis, prognosis, and monitoring of rheumatic, autoimmune, and related diseases, including systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). The company operates in one operating segment. The majority of the company's revenue is derived from sales of its testing products.
MoneyHero Ltd is a tech- and AI-powered personal finance aggregation and comparison platform and a digital insurance brokerage provider in Greater Southeast Asia. It operates in Singapore, Hong Kong, Taiwan and the Philippines. Its brand portfolio includes B2C platforms MoneyHero, SingSaver, Money101, Moneymax and Seedly, as well as the B2B platform Creatory. The company has four operating and reportable segments: Hong Kong, Singapore, the Philippines, and Taiwan. The Hong Kong segment generates the majority of the revenue.